Apolipoprotein E, dementia and strokes

Journal of the Neurological Sciences

Volumn 206, Issue 1, 2003, Pages 3-5

  Korzcyn, Amos D ^a   Chapman, Joab ^b  

^a TEL AVIV UNIVERSITY   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

ALZHEIMER DISEASE; ATHEROSCLEROSIS; BLOOD VESSEL INJURY; CAROTID ARTERY; DEMENTIA; EDITORIAL; PRIORITY JOURNAL; RECURRENT DISEASE; RISK FACTOR; STROKE;

ALZHEIMER DISEASE; APOLIPOPROTEINS E; CEREBROVASCULAR ACCIDENT; DEMENTIA; HUMANS;

EID: 0037437651     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(02)00362-3     Document Type: Editorial

References (31)

1. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.D., Gaskell P.C., Small G.W.et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer disease in late onset families. Science. 26:1993;921-923.
2. Minthon L., Hesse C., Sjogren M., Englund E., Gustafson L., Blennow K. The apolipoprotein E-ipsolon4 allele frequency is normal in fronto-temporal dementia, but correlates with age at onset of disease. Neurosci. Lett. 226:1997;65-67.
3. Chapman J., Cervenakova L., Petersen R.B., Lee H.S., Estupinan J., Richardson S.et al. APOE in non-Alzheimer amyloidoses: transmissible spongiform encephalopathies. Neurology. 51:1998;548-553.
4. Bonarek M., Barberger-Gateau P., Letenneur L.et al. Relationships between cholesterol, apolipoprotein E polymorphism and dementia: a cross-sectional analysis from the PAQUID study. Neuroepidemiology. 19:2000;141-148.
5. Evans R.M., Emsley C.L., Gao S.et al. Serum cholesterol, APOE genotype, and the risk of Alzheimer's disease: a population-based study of African Americans. Neurology. 54:2000;240-242.
6. Jarvik G.P., Wijsman E.M., Kukull W.A., Schellenberg G.D., Yu C., Larson E.B. Interactions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction of Alzheimer's disease: a case-control study. Neurology. 45:1995;1092-1096.
7. Wood W.G., Koudinov A.R., Ohm T.G., Yanagisawa K., McLaurin J., Eckert G.P.et al. Cholesterol and Alzheimer's disease. Neurobiol. Lipids. 1(4):2002;1-12.
8. Bowirrat A., Friedland R.P., Chapman J., Korczyn A.D. The very high prevalence of AD in an Arab population is not explained by APOE ipsolon4 allele frequency. Neurology. 55:2000;731.
9. Osuntokun B.O., Sahota A., Ogunniyi A.O.et al. Lack of an association between apolipoprotein E epsilon 4 and Alzheimer's disease in elderly Nigerians. Ann. Neurol. 38:1995;463-465.
10. Kim J.-S., Han S.-R., Chung S.-W., Kim B.S., Lee H.S., Kim Y.I.et al. The apolipoprotein E ipsolon4 genotype is an important predictor for recurrence in ischemic cerebrovascular disease. J. Neurol. Sci. 2002.
11. Wilson P.W., Myers R.H., Larson M.G., Ordovas J.M., Wolf P.A., Schaefer E.J. Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. The Framingham offspring study. JAMA. 272:1994;1666-1671.
12. Cattin L., Fisicaro M., Tonizzo M., Valenti M., Danek G.M., Fonda K.et al. Polymorphism of the apolipoprotein E gene and early carotid atherosclerosis defined by ultrasonography in asymptomatic adults. Arterioscler. Thromb. Vasc. Biol. 17:1997;91-94.
13. de la Torre J.C. Alzheimer disease as a vascular disorder: nosological evidence. Stroke. 33:2002;1-3.
14. Korczyn AD. Mixed Dementia - The Most Common Cause of Dementia. 2002:1-10 [in press].
15. Frisoni G.B., Calabresi L., Geroldi C., Bianchetti A., D'Acquarica A.L., Govoni S.et al. Apolipoprotein E ipsolon 4 allele in Alzheimer's disease and vascular dementia. Dementia. 5:1994;240-242.
16. Walker L.C., Parker C.A., Lipinski W.J.et al. Cerebral lipid deposition in aged apolipoprotein-E-deficient mice. Am. J. Pathol. 151:1997;1371-1377.
17. Buttini M., Akeefe H., Lin C.et al. Dominant negative effects of apolipoprotein E4 revealed in transgenic models of neurodegenerative disease. Neuroscience. 97:2000;207-210.
18. Holtzman D.M., Bales K.R., Tenkova T.et al. Apoliprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 97:2000;2892-2897.
19. Raber J., Wong D., Buttini M.et al. Isoform-specific effects of human apolipoprotein E on brain function revealed in ApoE knockout mice: increased susceptibility of females. Proc. Natl. Acad. Sci. U. S. A. 95:1998;10914-10919.
20. Schiefermeier M., Kollegger H., Madl C., Polli C., Oder W., Kuhn H.-J.et al. The impact of apolipoprotein E genotypes on age at onset of symptoms and phenotypic expression in Wilson's disease. Brain. 123:2000;585-590.
21. Kanai M., Shizuka M., Urakami K., Matsubara E., Harigaya Y., Okamoto K.et al. Apolipoprotein E4 accelerates dementia and increases cerebrospinal fluid tau levels in Alzheimer's disease. Neurosci. Lett. 267:1999;65-68.
22. Chapman J., Vinokurov S., Achiron A., Karussis D.M., Mitosek-Szewczyk K., Birnbaum M.et al. APOE genotype is a major predictor of long-term progression of disability in multiple sclerosis. Neurology. 56:2001;313-316.
23. Drory V.E., Birnbaum M., Korczyn A.D., Chapman J.et al. Association of APOE epsilon4 allele with survival in amyotrophic lateral sclerosis. J. Neurol. Sci. 190:2001;17-20.
24. Horsburgh K., Cole G.M., Yang F., Savage M.J., Greenberg B.D., Gentleman S.M.et al. Beta-amyloid (Abeta)42(43), abeta42, abeta-40 and apoE immunostaining of plaques in fatal head injury. Neuropathol. Appl. Neurobiol. 26:2000;124-132.
25. Laskowitz D.T., Horsburgh K., Roses A.D. Apolipoprotein E and the CNS response to injury. J. Cereb. Blood Flow Metab. 18:1998;465-471.
26. Sabo T., Lomnitski L., Nyska A., Beni S., Maronpot R.R., Shohami E.et al. Susceptibility of transgenic mice expressing human apolipoprotein E to closed head injury: the allele E3 is neuroprotective whereas E4 increases fatalities. Neuroscience. 101:2000;879-884.
27. Mayeux R., Ottman R., Maestre G.et al. Synergistic effects of traumatic head injury and apolipoprotein-epsilon 4 in patients with Alzheimer's disease. Neurology. 45:1995;555-557.
28. Teasdale G.M., Nicoll J.A., Murray G., Fiddes M. Association of apolipoprotein E polymorphism with outcome after head injury. Lancet. 350:1997;1069-1071.
29. Statement on use of apolipoprotein E testing for Alzheimer disease. JAMA. 274:1995;1627-1629.
30. Petersen R.C., Smith G.E., Ivnik R.J., Tangalos E.G., Schaid D.J., Thibodeau S.N.et al. Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory impaired individuals. JAMA. 273:1995;1274-1278.
31. Yaffe K., Cauley J., Sands L., Browner W. Apolipoprotein E phenotype and cognitive decline in a prospective study of elderly community women. Arch. Neurol. 54:1997;1110-1114.